Several cancers of the nervous system were included in this study, revealing that DMD is significantly overexpressed in ependymoma and astrocytoma, but significantly under-expressed in medulloblastoma and non-significantly under-expressed in glioblastoma [43]. This evidence concerns the gene DMD and glioblastoma.